Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor.
Muhammed Muhiddin ErMurat ArazMeryem KarabacakMuzaffer UğraklıMelek Karakurt EryilmazMustafa KaraağaçMustafa YıldırımPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
A single case of primary adrenal insufficiency has been reported in the literature. We here present a case who developed hypoglycemia after pazopanib and was diagnosed with drug-associated secondary adrenal insufficiency. When hypoglycemia develops during pazopanib treatment, we must be aware of adrenal insufficiency.